Introduction
============

*Achromobacter* sp. is a nonfermenting Gram-negative bacterium, part of the *Burkholderiales* order, and considered an emerging opportunistic pathogen in the context of cystic fibrosis (CF) lung infections ([@evx061-B19]; [@evx061-B24]; [@evx061-B37]). Although it is not closely related to *Pseudomonas aeruginosa*, one of the most common causes of lung infection among CF patients ([@evx061-B25]), the two organisms are similar in many respects. Both carry relatively large genomes (6--7 Mb) and are ubiquitous in the environment, which is considered as the main source of infection ([@evx061-B63]; [@evx061-B6]; [@evx061-B42]), along with documented cases of cross-infection ([@evx061-B33]; [@evx061-B14], [@evx061-B15]). Moreover, like *P. aeruginosa*, *Achromobacter* sp. can outcompete resident microbiota ([@evx061-B75]), establish persistent chronic infections associated with inflammation ([@evx061-B32]; [@evx061-B44]), produce biofilm, resist common disinfectants ([@evx061-B38]; [@evx061-B31]) and readily acquire antibiotic resistance ([@evx061-B80]).

While its prevalence among CF patients is estimated to be as high as 10--20% ([@evx061-B44]; [@evx061-B80]), *Achromobacter* species can also cause infections such as bacteremia, pneumonia, meningitis, urinary tract infections, and nosocomial infections (reviewed in [@evx061-B1]). This may be the reason why, after a decade of stagnation, research focusing on clinical *Achromobacter* isolates was revived ∼10 years ago ([fig. 1](#evx061-F1){ref-type="fig"}). This increase in research interest was potentiated by the advent of next-generation sequencing technologies ([@evx061-B85]) and the explosion in the number of sequenced bacterial genomes that followed ([@evx061-B45]). As a result, most of the genomes available for the genus today are of clinical origin, while a few were sequenced in the context of bioremediation research. Despite this renewed interest, the *Achromobacter* genus suffers from a complex unresolved taxonomy ([@evx061-B83]), rare comparative genomics studies ([@evx061-B48]; [@evx061-B64]), and very limited understanding of how it adapts to the CF lung ([@evx061-B22]), let alone other host environments.F[ig]{.smallcaps}. 1.---*Achromobacter* research interest from a clinical perspective. As of June 3, 2016. The number of publications is based on a literature search using Web of Science ([www.webofknowledge.com](http://www.webofknowledge.com); last accessed June 3, 2016) with Title="Achromobacter" and Topic="clinical." The number of genomes is based on the content of NCBI.

In order to identify the genetic characteristics that allow some isolates to thrive in opportunistic infections, we combined all available *Achromobacter* genomes with four new genome sequences to perform the first large-scale comparative genomics study for this genus. More specifically, the goals were to (1) resolve the taxonomic uncertainties of the genus, and (2) identify virulence-associated genes, antimicrobial resistance genes, and other genomic features associated with pathogenicity and host adaptation. To achieve these goals, we developed an approach based on pan-genome analysis that could be applied to gain significant knowledge on any microbial species or genus.

Materials and Methods
=====================

DNA Preparation, Sequencing, and Assembly
-----------------------------------------

In the context of an international *Pseudomonas* genome project ([@evx061-B26]), we sequenced four *Achromobacter* genomes ([table 1](#evx061-T1){ref-type="table"}), one of which was already published: *A. xylosoxidans* CF304 ([@evx061-B38]). Bacterial colonies were isolated on Difco™ Pseudomonas Isolation Agar (BD, Sparks, MD). Genomic DNA was extracted from overnight cultures using the DNeasy Blood and Tissue Kit (QIAGEN, Hilden, Germany). Genomic DNA (500 ng) was mechanically fragmented for 40 s using a Covaris M220 (Covaris, Woburn, MA) with default settings. Fragmented DNA was transferred to a PCR tube and library synthesis was performed with the Kapa Hyperprep kit (Kapa biosystems, Wilmington, MA) according to manufacturer's instructions. TruSeq HT adapters (Illumina, SanDiego, CA) were used to barcode the libraries, which were each sequenced in 1/48 of an Illumina MiSeq 300 bp paired-end run at the Plateforme d'Analyses Génomiques of the Institut de Biologie Intégrative et des Systèmes (Laval University, Quebec, Canada). Each data set was assembled de novo with the A5 pipeline version A5-miseq 20140521 ([@evx061-B81]).Table 1New *Achromobacter* Genome AssembliesIsolate Name[^a^](#tblfn1){ref-type="table-fn"}SourceCityCountrySize (Mb)ContigsMedian Coverage[^b^](#tblfn2){ref-type="table-fn"}N50Accession*A. xylosoxidans* CF304[^c^](#tblfn3){ref-type="table-fn"}cf, sputumMontrealCanada6.32961586493NZ_LFHA00000000*A. xylosoxidans* 4124363476cf, throatRouyn-NorandaCanada6.84226503116MJMP00000000*A. xylosoxidans* AUS488bronchiectasis, sputumBrisbaneAustralia7.16520257078MJMN00000000*A. xylosoxidans* U400cf patientHobartAustralia6.56147275436MJMO00000000[^3][^4][^5]

Public Data Selection
---------------------

All genomes of the genus *Achromobacter* that had 200 scaffolds or less were downloaded from RefSeq (in June 2016). The 200-scaffold cut-off was selected as a compromise to ensure an assembly quality similar to our own (\<100 scaffolds), without having to eliminate too many genomes. A preliminary phylogenetic analysis showed that four genomes were extremely distant from the others: *Achromobacter* sp. ATCC8750 (NZ_CYTB01000000), *Achromobacter* sp. 2789STDY5608636 (NZ_CYTV00000000), *Achromobacter* sp. ATCC13047 (NZ_CYTA00000000) and *Achromobacter* sp. ATCC35328 (NZ_CYUC00000000). BLAST searches revealed that they respectively corresponded to *Alcaligenes*, *Bordetella*, *Enterobacter* and *Escherichia coli* isolates. Therefore, these genomes were excluded from this study. The final set of publicly available genomes used with accession numbers and source are provided in [supplementary file 1](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online.

Pan-Genome and Phylogenetic Analyses
------------------------------------

With the goal of obtaining a robust core genome phylogeny, that is based on conserved regions among genomes, we used the tool SaturnV (<https://github.com/ejfresch/saturnV>) with the "strictest" algorithm. Genes were considered as orthologous when they shared at least 50% identity over 85% of their length. Orthologous genes for which there was no ambiguous relationship (e.g. putative paralogous genes) were aligned (codon alignments) using PRANK version 150803 ([@evx061-B52]). Sites with no genetic variation were removed with BMGE version 1.02 ([@evx061-B17]). The resulting alignments were concatenated into a matrix of 595,807 sites and the best-fit evolutionary model was chosen using jModelTest version 2.1.7 ([@evx061-B18]).

The phylogenetic analysis was performed by maximum-likelihood using RAxML version 8.1.17 ([@evx061-B74]) under the model GTR + Γ4 with 1000 rapid bootstraps. The resulting tree was visualized and midpoint rooted using FigTree version 1.4.3 (<http://tree.bio.ed.ac.uk/software/figtree/>; last accessed June 15, 2016). Average nucleotide identity (ANI) analysis between all genome pairs was performed using pyani (<https://github.com/widdowquinn/pyani>; last accessed June 15, 2016) with the MUMmer algorithm ([@evx061-B43]). Species identification was supported by comparisons with molecular typing data ([@evx061-B39]).

Genes under Selection
---------------------

The second goal of this study was to identify genomic features associated with pathogenicity. After the phylogenetic analysis demonstrated that clinical isolates tended to cluster together, we sought to identify genes that were under positive selection (d*N*/d*S* \> 1) in these clusters specifically. Previously generated orthologous gene alignments were analyzed with HyPhy version 2.2.4 ([@evx061-B62]) using the adaptive branch-site random effects likelihood (aBSREL) method ([@evx061-B72]). A gene was considered under positive selection for a given node or tip in the tree if the *P* value, after correction for multiple testing with the Holm--Bonferroni method, was \<0.05.

Accessory Genome Diversity and Association Analyses
---------------------------------------------------

The core genome phylogeny does not take into account information from the accessory genome, that is the genes that are not conserved among isolates. In order to determine whether this information was consistent with the core genome phylogeny, we used a binary matrix of presence/absence for all flexible genes, that is nonunique accessory genes. Genes that are unique to a given genome are uninformative and were excluded from the following analyses. We first assessed flexible gene diversity and relatedness among genomes with a principal component analysis (PCA) and hierarchical clustering using R package ade4 ([@evx061-B21]). We then used a discriminant analysis of principal components (DAPC) using R package adegenet ([@evx061-B40]) to identify genes that are most discriminant between isolates of clinical and nonclinical origin. The goal of this analysis was mainly to find genes that are beneficial in the context of opportunistic infection. To specifically look at gene presence/absence in the context of virulence, we also extracted all annotated virulence genes for *Achromobacter* genomes on PATRIC ([@evx061-B86]).

Open/Closed Pan-Genome
----------------------

In order to calculate how the pan-genome size increases as a function of the number of genomes sampled, 10 sets of the 29 *A. xylosoxidans* genomes in which the order of the genomes was randomly assigned were generated. For each set, the first n genomes (1 ≤ *n* ≤ 29) were selected and the number of genes in the pan-genome was calculated using the output table generated by SaturnV, using an R script. To calculate how many new genes are discovered while adding a new genome to a data set of *n*−1 genomes (1 ≤ *n* ≤ 29), the same 10 sets were used by subtracting the pan-genome size of n genomes from that of *n*−1 genomes.

Mobilome Analysis
-----------------

With the aim of detecting horizontal gene transfer events between *Achromobacter* isolates and other prokaryotes, we developed two approaches instead of relying on existing tools, because they generally require raw sequencing data, which was not available for our complete data set.

The first approach to investigate the mobilome directly targeted plasmid elements. All protein sequences coded by each genome (according to the annotation) were compared with the NCBI database of proteins found on plasmids ([ftp://ftp.ncbi.nlm.nih.gov/refseq/release/plasmid/](http://ftp://ftp.ncbi.nlm.nih.gov/refseq/release/plasmid/); last accessed November 1, 2016). The software used to perform the sequence comparisons was Usearch v8.1.1861 ([@evx061-B23]), with a threshold of 50% protein sequence identity. Modules of five or more contiguous proteins found on the same strand were identified. For each module, the list of unique species where the proteins of the module were found was determined using the annotation present on the NCBI database of proteins found on plasmids. With this information, a network that connects *Achromobacter* to other genera was drawn using Cytoscape 3.3 ([@evx061-B70]). Another network representing how the modules are shared among *Achromobacter* isolates was also drawn using Cytoscape.

The second approach was based on finding regions of high nucleotide identity between *Achromobacter* genomes and genomes from other genera. More specifically, MegaBLAST (BLAST Tools version 2.4.0, using default parameters) ([@evx061-B5]) searches were conducted for each *Achromobacter* genome against the NCBI nucleotide database (nt, downloaded on September 9, 2016) while excluding the *Achromobacter* genus. BLAST results were filtered to select alignments of at least 5 kb in length and 95% identity. Redundancy was removed for each BLAST result using the longest alignment as a reference and removing smaller alignments that were included in this reference. Two hundred sequences ranging from 5,026 to 121,784 bp were thus extracted. In this work, we refer to these sequences as putative mobile genetic elements (MGEs). Putative MGEs were annotated with the RAST webserver (<http://rast.nmpdr.org/>; last accessed November 1, 2016, [supplementary file 2](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). A nonredundant table of MGE proteins along with their functional category was generated with the SEED-Viewer environment available in RAST ([supplementary files 3 and 4](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). We generated a final, nonredundant list of putative MGEs, such that two MGEs were considered the same element if they aligned with each other with \>95% identity and no more than 5% variation in length at both ends, always retaining the longest element as the reference. This step reduced the number of sequences to 158 elements ([supplementary file 2](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online, column "contig_id," non-redundant_database = Yes). MegaBLAST searches were conducted once again with the nonredundant list of putative MGEs against the NCBI nucleotide database (nt, downloaded September 9, 2016) while excluding the *Achromobacter* genus, and the BLASTn results were visualized using MEGAN5 ([@evx061-B36]).

Resistome Analysis
------------------

Antimicrobial resistance (AMR) genes were identified in all genomes based on the Comprehensive Antibiotic Resistance Database (CARD) ([@evx061-B53]). This was done using the command-line version of the Resistance Gene Identifier (RGI) software, version 3.0.9 ([@evx061-B53]). This software is based on BLASTp search against the CARD and uses curated e-value cut-offs to determine the presence of genes.

Results
=======

Genome Sequencing and Public Data Selection
-------------------------------------------

For comparative genomics analyses, all genomes of the genus *Achromobacter* were downloaded from RefSeq. Four genomes were excluded because they were incorrectly classified on NCBI (see Methods). The final set of 55 publicly available genomes used with accession numbers and isolation source are provided in [supplementary file 1](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online. We also sequenced four *Achromobacter* genomes, one of which was released prior to this study ([@evx061-B38]). Newly available genomes have been deposited on NCBI as part of BioProject PRJNA343957. [Table 1](#evx061-T1){ref-type="table"} contains descriptions and accession numbers for these four genomes, along with assembly statistics.

Phylogenetic Reconstruction
---------------------------

Pan-genome analysis on 59 *Achromobacter* genomes revealed that the gene inventory of this genus contained a total of 26,365 genes: 12,272 were unique to specific genomes, 12,252 were shared among two or more genomes ("flexible genes"), and 1,841 represented the conserved core genome (31.6% of an average genome). The first goal of this study was to provide a strong phylogenetic basis for the classification of this group. To achieve this, we generated a maximum likelihood tree based on the 1,780 conserved genes that had no ambiguous paralogous relationships. We also computed the average nucleotide identity (ANI) between genome pairs. ANI is a measure of genetic similarity that is used to define boundaries between different species ([@evx061-B41]), such that a value of 94% or more is indicative of two genomes being part of the same species. The phylogenetic tree and ANI data were combined ([fig. 2](#evx061-F2){ref-type="fig"}) to obtain a detailed overview of the *Achromobacter* phylogeny along with a cross-validation of the two methods. The tree itself was highly robust, with 100% bootstrap values on all basal nodes, and well supported by the ANI results. Of the five labelled groups, group 5 was the most abundant in our data set. According to molecular typing ([@evx061-B39]), the largest cluster (c) at the bottom of group 5, which included all four of our newly sequenced genomes, corresponded to *A. xylosoxidans* (*nrdA* 765 types 14, 36 and 42). It was very closely related to two other clusters, which comprised *A. insuavis* (cluster a, *nrdA* 765 types 45 and 51), *A. dolens* (cluster b, isolate *A.* sp. 2789STDY5608607, *nrdA* 765 type 90) and *A. ruhlandii* (cluster b, 5 isolates, *nrdA* 765 types 20 and 23). As for the remainder of the tree, including groups 1--3 as well as *A. sp.* DH1f from group 4, both ANI and branch length suggested that almost every genome was its own species. By labeling genomes based on isolation source, we found that group 5 included 95% of clinical isolates from CF and non-CF human infections, while this frequency dropped to 20% for the rest of the tree (Fisher's exact test: *P* \< 0.0001). Hence, understanding the genomic characteristics that differentiate this group from the rest of the *Achromobacter* genus became a central aspect of this study.F[ig]{.smallcaps}. 2.---*Achromobacter* core genome phylogeny. Midpoint rooted maximum likelihood tree of 59 *Achromobacter* genomes based on 595,807 core SNPs and computed with RAxML. Results from 1,000 bootstraps are indicated for basal nodes. Colored ovals represent the isolation source. The bottom scale represents substitutions per site. Genomes presented in this paper are identified with an asterisk. The heat map represents an all-against-all matrix of average nucleotide identity (ANI) between pairs of isolates. Horizontal lines were included to separate clusters where ANI ≥94%, which indicates that genomes are part of the same species ([@evx061-B41]). According to molecular typing ([@evx061-B39]): cluster a is *A. insuavis* (six isolates, *nrdA* 765 types 45 and 51), cluster b is *A. dolens* (A. sp. 2789STDY5608607, *nrdA* 765 type 90) and *A. ruhlandii* (five isolates, *nrdA* 765 types 20 and 23), and cluster c is *A. xylosoxidans* (29 isolates, *nrdA* 765 types 14, 36 and 42). Labels for groups 1--5 were arbitrarily included for reference in the main text.

Positively Selected Genes in the Core Genome
--------------------------------------------

The second goal of this study was to identify genomic features associated with pathogenic success. Considering the apparent phylogenetic clustering of clinical isolates, we sought to identify genes under positive selection that were specific to group 5. All genes that had a nonsynonymous to synonymous substitution rate ratio (d*N*/d*S*) significantly \>1, that is under positive selective pressures, for any given node or tip in the tree are listed in [supplementary file 5](#sup1){ref-type="supplementary-material"} (supported by [supplementary file 6](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online), whereas those that were specific to group 5 and/or group 4 (group 5 plus its closest relative) are summarized in [table 2](#evx061-T2){ref-type="table"}. These 35 genes included 15 metabolic genes, 8 genes related to regulation (for transcription, translation or post-translational modification), and 3 genes implicated in antibiotic resistance, all of which encode efflux pump components. Moreover, two positively selected genes were involved in nitrogen metabolism, one directly and the other indirectly, by being implicated in the synthesis of molybdenum cofactor (MoCo), which is essential for molybdoenzymes such as nitrate reductase.Table 2Genes under Positive Selection in Groups 4 and 5 of the *Achromobacter* GenusNode(s)[^a^](#tblfn4){ref-type="table-fn"}Annotation[^b^](#tblfn5){ref-type="table-fn"}KEGG Pathway(s)[^c^](#tblfn6){ref-type="table-fn"}COG Functional Category[^d^](#tblfn7){ref-type="table-fn"}Group 5Indole-3-glycerol phosphate synthaseKEGG:00400 Phenylalanine, tyrosine and tryptophan biosynthesisAmino acid transport and metabolismGroup 5Sulfate/thiosulfate import ATP-binding protein CysAnaAmino acid transport and metabolismGroup 5High-affinity branched-chain amino acid transport system permease protein LivNnaAmino acid transport and metabolismGroup 5Phospho-2-dehydro-3-deoxyheptonate aldolase, Phe-sensitiveKEGG:00400 Phenylalanine, tyrosine and tryptophan biosynthesisAmino acid transport and metabolismGroup 5, group 4aromatic amino acid exporternaAmino acid transport and metabolisma\*, b\*, c\*, group 5, group 4putative D, D-dipeptide transport system permease protein DdpCnaAmino acid transport and metabolism, Inorganic ion transport and metabolisma\*, group 5Sialic acid TRAP transporter permease protein SiaTnaCarbohydrate transport and metabolismGroup 5GlcNAc-PI de-N-acetylasenaCarbohydrate transport and metabolismGroup 5Prolipoprotein diacylglyceryl transferaseKEGG:00601 Glycosphingolipid biosynthesis---lacto and neolacto series KEGG:00604 Glycosphingolipid biosynthesis---ganglio seriesCell wall/membrane/envelope biogenesisGroup 5Molybdopterin-synthase adenylyltransferasenaCoenzyme transport and metabolismGroup 5Energy-coupling factor transporter transmembrane protein BioNnaCoenzyme transport and metabolismcMultidrug export protein EmrAnaDefense mechanisms[^e^](#tblfn8){ref-type="table-fn"}c\*, group 5Multidrug resistance protein MexBnaDefense mechanisms[^e^](#tblfn8){ref-type="table-fn"}Group 5Macrolide export protein MacAnaDefense mechanisms[^e^](#tblfn8){ref-type="table-fn"}, Cell wall/membrane/envelope biogenesisc^†^Cytochrome bo(3) ubiquinol oxidase subunit 3KEGG:00965 Betalain biosynthesisEnergy production and conversionb\*, cSuccinate dehydrogenase hydrophobic membrane anchor subunitnaEnergy production and conversionc, group 4Nitrite reductase (NADH) small subunitKEGG:00910 Nitrogen metabolismInorganic ion transport and metabolism, Secondary metabolites biosynthesis, transport and catabolismGroup 52,3-dehydroadipyl-CoA hydratasenaLipid transport and metabolismGroup 53-oxoadipate CoA-transferase subunit BnaLipid transport and metabolismcNAD-dependent protein deacetylasenaPost-translational modification, protein turnover, chaperonesGroup 5Protease HtpXnaPost-translational modification, protein turnover, chaperonesGroup 5putative 3′-5′ exonuclease related to the exonuclease domain of PolBnaReplication, recombination and repairGroup 5Isocitrate dehydrogenase kinase/phosphataseKEGG:00051 Fructose and mannose metabolism KEGG:00053 Ascorbate and aldarate metabolism KEGG:00565 Ether lipid metabolism KEGG:00600 Sphingolipid metabolism KEGG:00730 Thiamine metabolism KEGG:00740 Riboflavin metabolism KEGG:00760 Nicotinate and nicotinamide metabolismSignal transduction mechanismsGroup 5hypothetical proteinnaSignal transduction mechanismsGroup 5, group 4hypothetical proteinnaSignal transduction mechanismsGroup 5, group 4Transcriptional regulatory protein QseBnaSignal transduction mechanisms, Transcriptionc, group 4Transcriptional activator FeaRnaTranscriptionGroup 5HTH-type transcriptional activator CmpRnaTranscriptionGroup 5Valine--tRNA ligaseKEGG:00970 Aminoacyl-tRNA biosynthesisTranslation, ribosomal structure and biogenesisa\*, group 5, group 47-cyano-7-deazaguanine synthaseKEGG:00790 Folate biosynthesisTranslation, ribosomal structure and biogenesisc\*, group 5Cysteine--tRNA ligaseKEGG:00970 Aminoacyl-tRNA biosynthesisTranslation, ribosomal structure and biogenesisGroup 5hypothetical proteinnanaGroup 5Hydroxyacylglutathione hydrolasenanaGroup 5putative hydrolasenanaGroup 5, group 4hypothetical proteinnana[^6][^7][^8][^9][^10]

Pan-Genome and Accessory Genome Diversity
-----------------------------------------

A large part of the pan-genome resides in the accessory genome, that is genes that are not conserved among isolates. Comparing the presence/absence of accessory genes among genomes allowed us to produce a global portrait of genome architecture variability. More specifically, a principal component analysis (PCA) based on presence/absence of the 12,252 flexible genes showed that accessory gene content was consistent with the classification that emerged from the core genome phylogeny. In [figure 3*a*](#evx061-F3){ref-type="fig"}, Axis 1 (24% explained variance) separated species of group 4, formed by *A. xylosoxidans*, *A. ruhlandii*, *A. dolens*, *A. insuavis*, and isolate *A.* sp. DH1f from other species. Axis 2 (8% explained variance), on the other hand, discriminated *A. xylosoxidans* from other members of group 4*.* Representing the same analysis, but with labeling based on clinical or nonclinical isolation source, showed that accessory genome content is more consistent with evolutionary history than with sampling source ([fig. 3*b*](#evx061-F3){ref-type="fig"}).F[ig]{.smallcaps}. 3.---Principal component analysis of accessory gene content in *Achromobacter*. PCA analyses based on the presence/absence of 12,252 nonunique accessory (flexible) genes. Inertia ellipses are used to represent groups of genomes. Percentage of the variance explained by principal components 1 and 2 are shown on axes 1 and 2, respectively. (*a*) The 59 genomes are labelled based on previous core genome phylogeny. (*b*) Genomes are colored according to their isolation source (clinical: CF and human non-CF, nonclinical: environmental and animal). Four genomes had unknown sources, hence this panel represents 55 genomes instead of 59.

By studying how pan-genome size increases as a function of the number of genomes sampled, it is possible to estimate our knowledge of a species' genetic repertoire as well as to get some insight on its lifestyle. Using *A. xylosoxidans*, which had the largest data set, we first constructed a rarefaction curve ([fig. 4*a*](#evx061-F4){ref-type="fig"}) showing that with 28 sequenced genomes, new genes were still being discovered when adding an additional genome. This pattern is the signature of an open pan-genome, in opposition to a closed pan-genome, where pan-genome size stabilizes after just a few sequenced genomes ([@evx061-B76]). A large genome size coupled to an open pan-genome typically characterize species living in a community with high levels of lateral gene transfer ([@evx061-B66]). From these results, it was possible to estimate that, on an average, 133 new genes were discovered by adding a genome to a data set of *n*−1 isolates, where n is the number of isolates (1 ≤ *n* ≤ 29, [fig. 4*b*](#evx061-F4){ref-type="fig"}). We were also able to estimate that at least 50 high-quality genomes would be required to obtain a better survey of this species' genetic repertoire.F[ig]{.smallcaps}. 4.---Pan-genome size and new gene discovery in the pan-genome of *Achromobacter xylosoxidans*. (*a*) Twenty-nine genomes were randomly sampled 10 times and the number of genes present in the pan-genome was calculated for the first *n* genomes of each sample. The curve thus represents the mean of 10 independent observations. The grey area around this curve represents the standard deviation from the mean. (*b*) For each of the 10 samples described earlier, the number of new genes found in the pan-genome when an additional genome was added to the previous *n*−1 genomes (1≤*n*≤29) was plotted. The curve represents the mean of the 10 observations. Grey dots represent individual observations. The dashed line represents a linear fit to the nearly linear part of the curve (*n*≥10).

To investigate the accessory genome in the context of pathogenicity, we compiled genes associated with virulence for each phylogenetic lineage ([table 3](#evx061-T3){ref-type="table"}). For most virulence factor categories, namely the type III secretion system (T3SS), endotoxins and proteases, associated genes were more common, but not exclusive to group 5.Table 3Virulence-Associated Genes in *Achromobacter* Species**Virulence Genes**[^a^](#tblfn9){ref-type="table-fn"}**Species**[^b^](#tblfn10){ref-type="table-fn"}Other (18)*A. insuavis* (6)*A. ruhlandii/dolens* (6)*A. xylosoxidans* (26)Endotoxin Glutamate--UDP-2-acetamido-2-deoxy-D-ribohex-3-uluronic acid aminotransferase (PLP cofactor) (EC 2.6.1.98)22114 Putative oxidoreductase22114 UDP-2-acetamido-3-amino-2,3-dideoxy-D-glucuronic acid acetyltransferase (EC 2.3.1.201)22114Invasion Chemotaxis regulator---transmits chemoreceptor signals to flagelllar motor components CheY146626 Flagellar motor switch protein FliN2Protease, serine protease Mobile element protein3113 Transposon Tn21 resolvase3 TnpA transposase2 Integron integrase IntI121 Resolvase family recombinase1 Streptomycin 3\'\'-O-adenylyltransferase (EC 2.7.7.47), Spectinomycin 9-O-adenylyltransferase1Secretion, invasion, motility Flagellar basal-body rod protein FlgC1Secretion, Type III secretion system Type III secretion cytoplasmic ATP synthase (EC 3.6.3.14, YscN,SpaL,MxiB,HrcN,EscN)56622 Type III secretion inner membrane channel protein (LcrD,HrcV,EscV,SsaV)26619 Type III secretion inner membrane protein (YscS,homologous to flagellar export components)56619 Type III secretion inner membrane protein (YscR,SpaR,HrcR,EscR,homologous to flagellar export components)3Secretion, Type III secretion system, Invasion Nicotinamidase family protein YcaC71Serum resistance Inner membrane protein YihY, formerly thought to be RNase BN66626Other virulence factors 5-Enolpyruvylshikimate-3-phosphate synthase (EC 2.5.1.19)76626 Argininosuccinate synthase (EC 6.3.4.5)176626 Lipid A biosynthesis lauroyl acyltransferase (EC 2.3.1.241)56626 Translation elongation factor Tu176626 Imidazole glycerol phosphate synthase cyclase subunit (EC 4.1.3.-)186525 RNA-binding protein Hfq186625 LSU ribosomal protein L36p, LSU ribosomal protein L36p, zinc-dependent135624 RecA protein184522 MotA/TolQ/ExbB proton channel family protein8427 RNA polymerase sigma factor RpoE1 Chorismate synthase (EC 4.2.3.5)1[^11][^12]

Resistome and Mobilome
----------------------

In order to further characterize clinically relevant genomic features in *Achromobacter*, we identified genes associated with antibiotic resistance ([fig. 5](#evx061-F5){ref-type="fig"}). Species of group 5 carried more resistance genes than other species (Fisher's exact test *P* = 0.0003), namely for resistance against aminoglycosides (six additional genes), beta-lactams (six additional genes), chloramphenicol (three additional genes) and sulfonamides (two additional genes).F[ig]{.smallcaps}. 5.---Antimicrobial resistance (AMR) genes among *Achromobacter* genomes. Gene presence was determined using the RGI-CARD ([@evx061-B53]). Genomes are ordered based on the phylogenetic tree ([fig. 2](#evx061-F2){ref-type="fig"}), and vertical lines represent putative species boundaries. AMR genes are grouped by antibiotic family or function. Green: perfect match to a gene in the CARD, red: similar to a gene in the CARD, according to curated cut-offs, black: no match in the CARD, *gyrA* and *rpoB* mutants: specific variants conferring resistance, \* Genomes presented in this paper, † Genes with a significant difference in frequency between group 5 (four labelled species) and the other isolates (Fisher's exact test *P*\<0.05).

Some of these results clarified observations from previous gene-specific, PCR-based studies. For instance, [figure 5](#evx061-F5){ref-type="fig"} shows that OXA-114a, which has been used to diagnose *A. xylosoxidans* infection ([@evx061-B82]) and encodes a constitutive β-lactamase ([@evx061-B20]), was present in *A. xylosoxidans*, whereas *A. ruhlandii* carried OXA-258 ([@evx061-B59]), and *A. insuavis* as well as *A. dolens* carried OXA-243. Analysis of the genomic context of these three sequences confirmed that they corresponded to the same locus, while OXA-2 was a different gene. Isolates outside group 5 did not have an OXA gene, except for closest relative *A.* sp. DH1f, which shared OXA-114a with *A. xylosoxidans*. Previous PCR-based studies, mostly because they were misguided by the incorrect classification of the genus, present different results regarding allelic variants and the presence of OXA genes in *Achromobacter* species, and should be treated with caution ([@evx061-B7]; [@evx061-B79][@evx061-B78]). [Figure 5](#evx061-F5){ref-type="fig"} also contains two previously described efflux protein complexes of the resistance--nodulation--division (RND) family. AxyABM ([@evx061-B10]), which is implicated in the efflux of β-lactams, fluoroquinolones and chloramphenicol, but not aminoglycosides, corresponds to MexAD--OprM in [figure 5](#evx061-F5){ref-type="fig"} and was present in all genomes of this study. The AxyXY--OprZ complex ([@evx061-B9]), which confers broad spectrum resistance, including intrinsic resistance to aminoglycosides and a possible role in acquired resistance as well, corresponds to MexC--AcrF--OprA in [figure 5](#evx061-F5){ref-type="fig"}. While MexC and AcrF were present in all genomes, OprA was absent in many species outside group 4. Still, a previous PCR-based study suggested that the entire AxyXY--OprZ operon was absent in aminoglycoside sensitive *Achromobacter* species ([@evx061-B11]), which is inconsistent with our results.

Some of the results from [figure 5](#evx061-F5){ref-type="fig"} suggested horizontal acquisition of resistance. For instance, among the six perfect matches to sequences in the Comprehensive Antibiotic Resistance Database (CARD), ANT(2\'\')-Ia, APH(6)-Id, *sul1* and *sul2* were annotated as plasmid or integron encoded, and present in multiple bacterial genera. Considering that lateral gene transfer is a major mechanism in the evolution of resistance, pathogenicity and virulence in bacteria ([@evx061-B57]), we decided to investigate mobile genetic material in a more formal manner using two independent approaches. First, we searched for modules of contiguous genes (≥ 5 genes) located in the same strand that matched entries of the NCBI plasmid database. This allowed us to identify 466 modules that are shared among isolates of the *Achromobacter* genus ([supplementary file 7](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). These modules have a large variance in their length (up to 44 genes) and their distribution within the genus ([supplementary file 8](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). We then sought to investigate with which bacterial genera these modules were exchanged. The most likely candidates were plant growth promoting *Sinorhizobium* ([@evx061-B34]), as well as *Ralstonia*, *Pseudomonas* and *Burkholderia*, which, like *Achromobacter*, are soil organisms that are also responsible for opportunistic infections, namely in CF ([@evx061-B51]) ([fig. 6*a*](#evx061-F6){ref-type="fig"}). To validate these results, we performed an orthogonal analysis based on the search for stretches of at least 5 kb with high nucleotide identity (≥ 95%) that are shared between *Achromobacter* and other genera. This method allowed the identification of 158 putative mobile elements ([supplementary file 2](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online, non-redundant_database = Yes), which are represented here using a tree of the taxa with which *Achromobacter* is likely to have exchanged these elements ([fig. 6*b*](#evx061-F6){ref-type="fig"}). The taxonomic content of this tree has much in common with [figure 6*a*](#evx061-F6){ref-type="fig"} (where outermost taxa names were removed for clarity), hence the two independent methods used to identify putative mobile genetic elements can validate and complement one another.F[ig]{.smallcaps}. 6.---Horizontal gene transfer between *Achromobacter* and other bacterial species. (*a*) Network showing the modules (five or more contiguous genes that match entries of the NCBI plasmid database and are present on the same strand) shared between *Achromobacter* isolates and other bacterial taxa. The color of each node reflects classification (grey to blue: different groups of proteobacteria; yellow: other bacterial species; violet: uncultured bacteria; outermost taxa labels were removed for clarity). A force-directed layout was used to draw the network so that the more a node is close to *Achromobacter*, the more it shares the same modules). (*b*) Tree showing the species with which putative mobile elements were exchanged. This analysis is based on a BLASTn search of *Achromobacter* DNA sequences (\>5 kb) matching those of other bacterial species (\>95% identity). MEGAN5 ([@evx061-B36]) was used to represent the BLAST results in the form of a tree. The ellipses' width and the numbers next to them represent the number of sequences shared with each species/genus. The colours reflect classification, like in panel (*a*).

RAST annotation of the protein sequences within putative mobile elements revealed that 27% of them participated in resistance to antibiotics and toxic compounds ([supplementary files 3 and 4](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). Of these 27%, most proteins were implicated in heavy metal resistance rather than antibiotic resistance, which reflects the overall genomic content of *Achromobacter* with respect to these functions ([@evx061-B37]). As a final analysis, we were interested in pinpointing the genes of the resistome that were also part of putative mobile elements. From the plasmid database approach, we found that 22 modules contained at least one AMR gene ([supplementary file 7](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online), while from the more general second approach, we identified 29 putative mobile elements with at least one AMR gene ([supplementary file 2](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). If both analyses were combined, a total of 26 different AMR genes out of the 49 represented in [figure 5](#evx061-F5){ref-type="fig"} were part of the putative mobilome.

Discussion
==========

Phylogeny and Species Boundaries in Achromobacter
-------------------------------------------------

According to sequence typing database PubMLST ([@evx061-B39]), which is by far the most comprehensive molecular database for this organism ([@evx061-B73]), there are over 18 *Achromobacter* species, only a subset of which have been fully genome sequenced. This study provides genome-wide evidence to support the classification of group 5, that is *A. xylosoxidans*, *A. ruhlandii*, *A. dolens* and *A. insuavis*. However, with respect to ANI and accessory genome content, *A. ruhlandii* and *A. dolens* should be part of the same species. Moreover, because species of group 5 are within the 93--95% ANI "grey zone" ([@evx061-B41]), it would be equally appropriate to classify them as subspecies. *Achromobacter xylosoxidans* is the most prevalent species of the genus among infected CF patients ([@evx061-B73]; [@evx061-B16]) as well as nonrespiratory clinical samples ([@evx061-B8]), followed in frequency by the three other species of group 5. This explains the over-representation of these species in our data set, as there is a clear sampling bias favoring clinical isolates in both typing and sequence databases. Still, the prevalence of *A. xylosoxidans*, *A. ruhlandii*, *A. dolens* and *A. insuavis* among clinical isolates combined to their phylogenetic clustering suggest that they are better adapted to cause opportunistic infections. If this is the case, *Achromobacter* evolution would be reminiscent of that of its closest relative, *Bordetella* ([@evx061-B48]), a largely pathogenic genus involved in human respiratory infections ([@evx061-B54]) that evolved from a metabolically versatile, environmental ancestor ([@evx061-B30]; [@evx061-B88]; [@evx061-B50]). As for the 18 genomes outside of group 5, our results suggest that they represent almost as many different species. More genome sequences would be required to confidently support taxonomic inference, but it is reasonable to assume that group 1 comprises *A. spanius* and *A. piechaudii*, and that *A. arsenitoxydans* is part of group 2.

Mechanisms of Adaptation to the Host
------------------------------------

A central goal of this study was to identify genomic features implicated in pathogenicity, or more broadly speaking, in adaptation to the human host environment. Based on the evolutionary tree of the *Achromobacter* genus, this goal became intimately linked to understanding the evolution of group 5, which we propose to call "the clinical lineage." In looking at both the core and the accessory genome, we found that this lineage of *Achromobacter* is likely to share adaptive mechanisms with other biological systems.

Identifying positively selected genes in the clinical lineage led us to find similarities with a study on within-host evolution of *Achromobacter* spp. in CF patients, where most mutated genes were involved in general metabolism, and some were related to virulence and antimicrobial resistance ([@evx061-B64]). Metabolic genes are often identified in screening approaches aimed at finding genes implicated in virulence, but, even though metabolism and virulence are known to be intimately linked, understanding of detailed mechanisms is extremely limited ([@evx061-B65]; [@evx061-B28]). Metabolism is key to adapt to host conditions and effectively compete against resident microbiota ([@evx061-B65]; [@evx061-B58]), hence it may not be surprising that almost half of positively selected genes in the clinical lineage were implicated in metabolic processes. This analysis also led to the identification of three antibiotic resistance genes, which will be discussed later on.

Although *Achromobacter* and *Pseudomonas* are distantly related bacteria, both are obviously well equipped to thrive in the CF lung environment. We found two possible common features between them, the first one pertaining to the type III secretion system (T3SS), which pathogenic bacteria use to inject effectors into host cells ([@evx061-B13]). A previous comparative genomics analysis of *Achromobacter* using only three genomes, one from a CF patient and two from environmental isolates, showed that some virulence genes, mostly T3SS related, were only present in the CF isolate ([@evx061-B48]). Considering that we had a larger data set, coupled to a better understanding of the evolutionary history of the genus, we compiled virulence gene presence per phylogenetic lineage. As suspected based on our observation that accessory genome content is largely influenced by evolutionary history, patterns of gene presence/absence are not as clear cut as was previously suggested. T3SS genes were more common in the clinical lineage, but they were not systematically present, and some of the other species carried them as well. The T3SS anciently evolved from the flagellum machinery ([@evx061-B2]) and is highly conserved among *Bordetella* and *Achromobacter* species. However, it may be absent in some isolates, which are generally, but not exclusively, nonpathogenic ([@evx061-B48]). Therefore, this virulence factor may have been lost during adaptation to environmental niches, or selected against in certain cases of chronic lung infection ([@evx061-B64]). This last mechanism is reminiscent of adaptation to the CF lung for *P. aeruginosa*, where virulence factor loss is thought to be advantageous to evade host defenses ([@evx061-B56]; [@evx061-B71]).

The second potential mechanism that we identified relates to survival with limited oxygen. It was demonstrated that the CF mucus is oxygen depleted, prompting *P. aeruginosa* to use denitrification for energy production ([@evx061-B69]). Moreover, there is evidence that molybdenum uptake, upon which denitrification depends, is essential for anaerobic proliferation and influences virulence in this pathogen ([@evx061-B60]; [@evx061-B61]). Considering that most of the genomes of clinical origin used here are from CF patients, it was interesting to find two positively selected genes involved in nitrogen metabolism, suggesting that *Achromobacter* and *P. aeruginosa* may share this adaptive mechanism to the CF lung environment.

Flexible and Mobile Genomic Diversity
-------------------------------------

We have shown that accessory genome content generally matches evolutionary history more than it does ecological niche. These results are consistent with a study on opportunistic pathogen *P. aeruginosa*, where no correlation was found between genome content and infection type or environmental source ([@evx061-B87]). Nevertheless, using a discriminant analysis of principal components (DAPC), we attempted to identify genes that were specific to isolates of clinical or nonclinical origin. The 28 most discriminant genes identified (based on loading \> 0.001, i.e. above background noise) are listed in [supplementary file 9](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online. It is noteworthy that many of them are consecutive (locus tags separated by increments of 5), and are likely part of prophages or genomic islands. Especially among genes that were more common among clinical isolates, we identified multiple hypothetical proteins, highlighting the fact that genes with unknown function may play very important roles. Among characteristic genes of nonclinical isolates, this analysis revealed an arsenic efflux pump protein. This is interesting, considering that arsenic resistance is a staple of contaminated soil isolate *A. arsenitoxidans* SY8 ([@evx061-B47]), although this result is influenced by the presence of multiple contaminated site isolates in our data set.

Compiling the number of genes found as a function of the number of genomes available showed that each new *A. xylosoxidans* genome results in gene discovery, which corresponds to the concept of an open pan-genome. It was suggested that this type of pan-genome reflects a need for high adaptability in the face of diverse environmental conditions, which may translate into high levels of lateral gene transfer among organisms ([@evx061-B76]). This result motivated a systematic search for mobile genetic material in the *Achromobacter* genus. Using two independent approaches, we found putative mobile elements that support past exchange of genetic material between *Achromobacter* and bacterial genera that share the same ecological setting, without assumptions on the direction of this exchange. Considering that many of these other genera are also environmental organisms capable of causing opportunistic infections, determining whether gene transfer in the soil has predominated over gene transfer in host environments is far from being trivial, although it is probably reasonable to assume that this mechanism has played an important role in both cases. It is now widely recognized that horizontal gene transfer is key to rapid adaptation in the contexts of infectious disease, plant symbiosis and bioremediation ([@evx061-B27]), all of which are relevant to the ecology of *Achromobacter*.

While they yielded a similar taxonomic breakdown of gene exchange, results of the two approaches used here to find evidence of horizontal transfer shared 338 proteins, representing only 6.6% of the plasmid-related proteins and 19.4% of the putative mobile element proteins. This is due to the fact that the first approach uses a less stringent identity cut-off, thus allowing the identification of more distantly related elements, while the second approach, with a 95% sequence identity cut-off, has a clear bias in favor of more recent transfer events. Thus, the two methods are complementary in this respect. It is also important to note that these results likely include false positives in the form of conserved regions inherited from a common ancestor, for example between *Achromobacter* and *Bordetella*. Within their overlapping results, there were 9 AMR genes: *aadA25*, *acrF*, *ceoB*, *cmlA1*, *golS*, *mexQ*, *mexT*, *sul1* and *sul2*. Five of them (*aadA25*, *cmlA1*, *golS*, *sul1* and *sul2*) were infrequent among *Achromobacter* isolates, which is what would be expected in cases of acquired resistance ([@evx061-B35]).

Antibiotic Resistance
---------------------

It has been known for some time that *Achromobacter* species have innate resistance against multiple antibiotics, namely cephalosporins (beta-lactam), aztreonam (beta-lactam), and aminoglycosides ([@evx061-B29]; [@evx061-B68]; [@evx061-B4]), which include antibiotics relevant to CF lung infection treatment ([@evx061-B77]). Most likely due to the selective pressures that they have undergone, our results show that isolates of the clinical lineage carry more resistance genes than other isolates, namely for resistance against aminoglycosides, beta-lactams, chloramphenicol and sulfonamides. These additional genes presumably contribute to acquired resistance. There are certain limitations to the approach used here to identify genes of the resistome. First, EmrA, while it was annotated as an AMR gene and found to be under positive selective pressures, was not detected in the analysis presented in [figure 5](#evx061-F5){ref-type="fig"}. Second, even if a gene is present and reasonably similar to a known AMR gene, there is no guarantee that it is expressed, or even functional. These issues highlight the need for tools that are not database dependant, especially when it comes to organisms that remain to be well described like *Achromobacter*. Unfortunately, identifying the genetic basis of a trait de novo requires a large data set of both genotypes and phenotypes ([@evx061-B12]), which is simply not available at the moment for this organism.

Three genes encoding efflux pump components were under positive selection in the clinical lineage: (1) EmrA, a periplasmic fusion protein part of a major facilitator superfamily multidrug export complex (2) MacA, the periplasmic fusion part of an ABC efflux pump that exports macrolides, and (3) MexW, the multidrug transporter of a RND-type efflux pump. The periplasmic fusion protein is essential to anchor the inner membrane transporter and the outer membrane channel in tripartite efflux systems; it can even play a regulatory role ([@evx061-B49]; [@evx061-B55]). Although efflux pumps are anciently evolved systems, substrate changes have been observed relatively frequently in prokaryotes ([@evx061-B67]) and show a tendency to favor loss of specificity, which translates into multi-resistance ([@evx061-B46]; [@evx061-B84]). Moreover, efflux pumps do not exclusively export antimicrobials, and studies on multiple pathogens suggest that they are implicated in bacterial virulence as well ([@evx061-B3]). Hence, efflux pump components, which are generally part of the core genome, represent potent targets for adaptation to a pathogenic lifestyle.

Conclusion
==========

With this study, we first provide a strong phylogenetic basis upon which further research efforts on *Achromobacter* classification, identification and evolution can build. Second, we show that pathogenicity and host adaptation in this opportunistic pathogen can rest both on elements of the conserved core genome, such as metabolic, regulatory and efflux components, as well as accessory elements, such as virulence-associated and antibiotic resistance genes, which may be horizontally acquired from other bacteria adapted to the same ecological niches. Third, we propose a general strategy to efficiently analyze and gain insight on any microbe's pan-genome. As emerging pathogens and drug resistance are increasingly recognized as serious healthcare issues (<http://www.who.int/antimicrobial-resistance/en/>; last accessed October 30, 2016), this work contributes to the critical understanding of how versatile environmental microbes evolve into serious threats to human health.
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[^3]: The phylogenetic analysis presented in [figure 2](#evx061-F2){ref-type="fig"} enabled species identification.

[^4]: Median depth of coverage in a de novo assembly with A5-MiSeq ([@evx061-B81]).

[^5]: This genome was previously published ([@evx061-B38]).

[^6]: Node(s) in the phylogenetic tree where positive selection (d*N*/d*S* \> 1) was detected. a: cluster formed by *A. insuavis*, b: cluster formed by *A. ruhlandii* and *dolens*, c: cluster formed by *A. xylosoxidans*, group 5: cluster formed by a + b + c, group 4: group 5 plus closest relative *A.* sp DH1f, \* positive selection on internal node or isolate, not on whole group, † positive selection on whole group in addition to internal nodes and isolates.

[^7]: Annotation with Prokka.

[^8]: Annotation with PATRIC.

[^9]: Annotation with SaturnV.

[^10]: EmrA: no match in the Comprehensive Antibiotic Resistance Database (CARD), MacA: match with CARD's *macA*, MexB: match with CARD's *mexW*.

[^11]: Virulence-associated genes were extracted from PATRIC ([@evx061-B86]), using a combination of databases Victors and VFDB.

[^12]: Species were determined based on previous core genome phylogeny, total number of genomes per species is indicated between parentheses.
